News

Topical ruxolitinib cream shows promise as a treatment for inflammatory skin conditions, but lacks consistent data, indicating a need for further research into its use across various dermatologic ...
Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.
In This Article People / David Hattan While there’s no such thing as Botox in a bottle, a skin-tightening cream can help target some common signs of aging. These creams are designed to do ...